Logo image of IRNT

IRONNET INC (IRNT) Stock Fundamental Analysis

NYSE:IRNT - New York Stock Exchange, Inc. - US46323Q1058 - Common Stock - Currency: USD

0.127  -0.01 (-6.55%)

After market: 0.13 +0 (+2.36%)

Fundamental Rating

1

Taking everything into account, IRNT scores 1 out of 10 in our fundamental rating. IRNT was compared to 283 industry peers in the Software industry. IRNT may be in some trouble as it scores bad on both profitability and health. IRNT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year IRNT has reported negative net income.
In the past year IRNT has reported a negative cash flow from operations.
IRNT Yearly Net Income VS EBIT VS OCF VS FCFIRNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

The profitability ratios for IRNT are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IRNT Yearly ROA, ROE, ROICIRNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 -500 -1K -1.5K

1.3 Margins

IRNT has a worse Gross Margin (33.25%) than 81.79% of its industry peers.
IRNT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for IRNT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.2%
GM growth 5YN/A
IRNT Yearly Profit, Operating, Gross MarginsIRNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400 -600 -800

0

2. Health

2.1 Basic Checks

IRNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IRNT has been increased compared to 1 year ago.
Compared to 1 year ago, IRNT has a worse debt to assets ratio.
IRNT Yearly Shares OutstandingIRNT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
IRNT Yearly Total Debt VS Total AssetsIRNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -32.87, we must say that IRNT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of IRNT (-32.87) is worse than 95.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -32.87
ROIC/WACCN/A
WACC10.18%
IRNT Yearly LT Debt VS Equity VS FCFIRNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M -40M -60M -80M

2.3 Liquidity

IRNT has a Current Ratio of 0.38. This is a bad value and indicates that IRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
IRNT has a worse Current ratio (0.38) than 94.64% of its industry peers.
IRNT has a Quick Ratio of 0.38. This is a bad value and indicates that IRNT is not financially healthy enough and could expect problems in meeting its short term obligations.
IRNT has a Quick ratio of 0.33. This is amonst the worse of the industry: IRNT underperforms 95.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.33
IRNT Yearly Current Assets VS Current LiabilitesIRNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.06% over the past year.
The Revenue for IRNT has decreased by -19.64% in the past year. This is quite bad
Measured over the past years, IRNT shows a small growth in Revenue. The Revenue has been growing by 5.58% on average per year.
EPS 1Y (TTM)59.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.49%
Revenue 1Y (TTM)-19.64%
Revenue growth 3Y5.58%
Revenue growth 5YN/A
Sales Q2Q%-14.73%

3.2 Future

The Earnings Per Share is expected to grow by 24.90% on average over the next years. This is a very strong growth
Based on estimates for the next years, IRNT will show a decrease in Revenue. The Revenue will decrease by -0.78% on average per year.
EPS Next Y33.33%
EPS Next 2Y24.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.95%
Revenue Next 2Y-0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IRNT Yearly Revenue VS EstimatesIRNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
IRNT Yearly EPS VS EstimatesIRNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

IRNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRNT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRNT Price Earnings VS Forward Price EarningsIRNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IRNT Per share dataIRNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as IRNT's earnings are expected to grow with 24.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.9%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IRNT!.
Industry RankSector Rank
Dividend Yield N/A

IRONNET INC

NYSE:IRNT (8/4/2023, 8:11:34 PM)

After market: 0.13 +0 (+2.36%)

0.127

-0.01 (-6.55%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-15 2023-06-15
Earnings (Next)09-12 2023-09-12
Inst Owners0%
Inst Owner Change0%
Ins Owners26.14%
Ins Owner Change0%
Market Cap14.20M
Analysts36.67
Price Target0.15 (18.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.28%
Min Revenue beat(2)8.29%
Max Revenue beat(2)10.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.55%
Min Revenue beat(4)-14.19%
Max Revenue beat(4)10.28%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.08
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0.24
BVpS-0.31
TBVpS-0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.25%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.2%
GM growth 5YN/A
F-Score4
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.08%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.33
Altman-Z -32.87
F-Score4
WACC10.18%
ROIC/WACCN/A
Cap/Depr(3y)147.77%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.49%
EPS Next Y33.33%
EPS Next 2Y24.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.64%
Revenue growth 3Y5.58%
Revenue growth 5YN/A
Sales Q2Q%-14.73%
Revenue Next Year-1.95%
Revenue Next 2Y-0.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.48%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y25.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.48%
OCF growth 3YN/A
OCF growth 5YN/A